Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a single-centre, phase 2 study
scientific article published on 29 September 2015
Author/s
author: Hagop Kantarjian, Stefan Faderl, Zeev Estrov, William G Wierda, Jorge Eduardo Cortes, Tapan Kadia, Susan O'Brien, Farhad Ravandi, Elias Jabbour, Marina Konopleva, Joseph D. Khoury, Naveen Pemmaraju, Courtney D DiNardo, Koji Sasaki, C Cameron Yin, Rebecca S Garris, Naval Daver, Jeffrey C. Jorgensen, Xuelin Huang, Guillermo Garcia-Manero, Zach Bohannan
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.